| Year |
Citation |
Score |
| 2018 |
Osborn SL, Kurzrock EA. In Vitro Differentiation and Propagation of Urothelium from Pluripotent Stem Cell Lines. Methods in Molecular Biology (Clifton, N.J.). 1655: 137-144. PMID 28889383 DOI: 10.1007/978-1-4939-7234-0_11 |
0.357 |
|
| 2017 |
Chan YY, Sandlin SK, Kurzrock EA, Osborn SL. The Current Use of Stem Cells in Bladder Tissue Regeneration and Bioengineering. Biomedicines. 5. PMID 28536347 DOI: 10.3390/Biomedicines5010004 |
0.311 |
|
| 2015 |
Osborn SL, Kurzrock EA. Production of urothelium from pluripotent stem cells for regenerative applications. Current Urology Reports. 16: 466. PMID 25404180 DOI: 10.1007/S11934-014-0466-6 |
0.352 |
|
| 2014 |
Osborn SL, Thangappan R, Luria A, Lee JH, Nolta J, Kurzrock EA. Induction of human embryonic and induced pluripotent stem cells into urothelium. Stem Cells Translational Medicine. 3: 610-9. PMID 24657961 DOI: 10.5966/Sctm.2013-0131 |
0.406 |
|
| 2010 |
Osborn SL, Diehl G, Han SJ, Xue L, Kurd N, Hsieh K, Cado D, Robey EA, Winoto A. Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis. Proceedings of the National Academy of Sciences of the United States of America. 107: 13034-9. PMID 20615958 DOI: 10.1073/Pnas.1005997107 |
0.504 |
|
| 2007 |
Osborn SL, Sohn SJ, Winoto A. Constitutive phosphorylation mutation in Fas-associated death domain (FADD) results in early cell cycle defects. The Journal of Biological Chemistry. 282: 22786-92. PMID 17553783 DOI: 10.1074/Jbc.M703163200 |
0.64 |
|
| 2005 |
Alappat EC, Feig C, Boyerinas B, Volkland J, Samuels M, Murmann AE, Thorburn A, Kidd VJ, Slaughter CA, Osborn SL, Winoto A, Tang WJ, Peter ME. Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities. Molecular Cell. 19: 321-32. PMID 16061179 DOI: 10.1016/J.Molcel.2005.06.024 |
0.583 |
|
| Show low-probability matches. |